Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.santini@uniroma1.it
Daniele Santini
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
daniele.santini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Emerging kinase inhibitors of the treatment of gastric cancer
EXPERT OPINION ON EMERGING DRUGS
2015
Deregulation of dicer and mir-155 expression in liposarcoma
ONCOTARGET
2015
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
SEMINARS IN CANCER BIOLOGY
2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
TARGETED ONCOLOGY
2015
Percutaneous long bone cementoplasty for palliation of malignant lesions of the limbs: a systematic review
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
2015
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter
CURRENT ONCOLOGY
2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
PLOS ONE
2015
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
ONCOTARGET
2015
Pembrolizumab for the treatment of non-small-cell lung cancer
NEW ENGLAND JOURNAL OF MEDICINE
2015
PD-1 blockade therapy in renal cell carcinoma. Current studies and future promises
CANCER TREATMENT REVIEWS
2015
Emerging drugs for the treatment of bone metastasis
EXPERT OPINION ON EMERGING DRUGS
2015
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone
THE PROSTATE
2015
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis
SUPPORTIVE CARE IN CANCER
2015
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis
EXPERT OPINION ON BIOLOGICAL THERAPY
2015
Role of c-mesenchymal-epithelial transition pathway in gastric cancer
EXPERT OPINION ON PHARMACOTHERAPY
2015
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
BRITISH JOURNAL OF CANCER
2015
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
JOURNAL OF HEMATOLOGY & ONCOLOGY
2015
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells
CANCER BIOLOGY & THERAPY
2015
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer
EXPERT OPINION ON INVESTIGATIONAL DRUGS
2015
« prima
< precedente
…
7
8
9
10
11
12
13
14
15
16
17
18
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma